Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; pp. ii48 - ii49
Main Authors: Paz-Ares, L., Doebele, R.C., Farago, A.F., Liu, S.V., Chawla, S.P., Tosi, D., Blakely, C.M., Krauss, J.C., Sigal, D., Bazhenova, L., John, T., Besse, B., Wolf, J., Seto, T., Chow-Maneval, E., Ye, C., Simmons, B., Demetri, G.D.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-04-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz063.011